BRUSSELS, BELGIUM – DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association, proudly launches a new brochure “Refurbishment of medical devices – Contribution to Circular Economy” in 5 Global languages: English, Japanese, French, Spanish and Chinese.
Back in 2007 COCIR, the European Trade Association representing the medical imaging, radiotheraphy, health ICT and electromedical industries, developed the concept of Good Refurbishment Practice (GRP) on how to efficiently and safely refurbish medical equipment.
The process, articulated in 5 key steps, is aimed at extending equipment’s life by restoring its performances and safety (as good as new) while reducing environmental impact and contributing to the circular economy.
Based on positive feedback by regulators and other key stakeholders around the globe, in June 2009 COCIR published a new version of this concept.
Since then, GRP was endorsed by the Medical Imaging & Technology Alliance (MITA) in the USA and the Japan Industries Association of Radiological Systems (JIRA), both members of DITTA.
The DITTA brochure launched today illustrates the importance of refurbishment of medical devices and parts in a circular economy and how it contributes to the 3 pillars of sustainability: (1) environment (saving energy and materials), (2) economy (contributing to cost efficiency of healthcare systems) and (3) society (improving the quality of healthcare).
Nicole Denjoy, DITTA Vice-Chair said, “Our initiative is embedded in a strategy towards circular economy. Refurbishment of medical equipment helps save energy and resources while preventing unnecessary waste. At the same time it allows access to affordable quality equipment. Our publication aims at educating stakeholders including healthcare providers, and institutions worldwide on the importance of a robust and sustainable global health system. DITTA industry is highly innovative and its member companies are frontrunners in minimizing the environmental impact”.
DITTA actively participated in the 8th IMDRF Conference held in Kyoto.
DITTA contributed to IMDRF with the following:
– Organising a Workshop on Standards on Monday 14 September
– Delivering the Industry views during the Stakeholder Forum on Wednesday 16 September. Click here to access presentation
DITTA Standards Workshop
“Standards for better regulatory framework”
Taking place during the 8th meetings of IMDRF in Kyoto, Japan
Monday 14 September 2015 from 09:00 to 12:30
Location: Shimadzu Corporation
1 Nishinokyo Kuwabara-cho, Nakagyo-ku, Kyoto 604-8511, Japan
Our motto as DITTA has been since long: “Approved once, accepted everywhere”. However, our practical goal is “to reduce multiple processes, cost and time loss” when putting new medical device and innovative technologies on the market.
DITTA requested IMDRF Management Committee to include standards in the Long Term goals and strategic plan. After that, IMDRF Management Committee decided to establish the strategic plan at the Kyoto meeting. With this Workshop, DITTA supports the introduction of Standards into the IMDRF strategic plan, by providing rationale and offering the possibility to discuss priorities and possible timing.
Detailed programme attached.
DITTA Calls For Immediate Inclusion Of ‘Technologies’ In United Nations Sustainable Development Goal 3
BRUSSELS, BELGIUM – DITTA, the Global Diagnostic Imaging, Healthcare IT and Radiation Therapy Trade Association, urgently calls for the inclusion of the word ‘technologies’ in the Sustainable Development Goal (SDG) 3, Target 3B, which highlights the importance of ensuring healthy lives and promoting well-being.
Sustainable Development Goals (SDGs) are set to be ratified at the United Nations (UN) General Assembly in September 2015. They are an expansion on the Millennium Development Goals (MDGs) agreed by governments in 2000.
DITTA is particularly concerned with the changes in Target 3B, SDG 3, where the word ‘technologies’, referring to medical technologies, has been deleted. DITTA wants ‘technologies’ after ‘medicines’ in the suggested final version of the Target 3B, SDG 3, as follows:
“3.b support research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines, technologies and vaccines, in accordance with the Doha Declaration which affirms the right of developing countries to use to the full the provisions in the TRIPS agreement regarding flexibilities to protect public health and, in particular, provide access to medicines for all.”
Nicole Denjoy, DITTA Vice-Chair, said, “Medical technology saves lives and this term should not be removed from SDG 3. Without medical technology, there would be no radiotherapy treatment for cancer, no infant warmers for babies suffering from hypothermia, no LED phototherapy for neonatal jaundice and the detection and cure of tuberculosis and HIV would not be possible. These are just some examples of medical technology’s contributions, taken from the World Health Organization’s (WHO) Compendium of innovative health technologies for low-resource settings.”
Nicole Denjoy added, “Medical technology is vital in diagnosing, monitoring and treating diseases. Without medical technologies, health systems would simply collapse. Therefore, it is an imperative for the term ‘technologies’ to be included in the SDG 3.”